Trial intelligence / Profile preview

Long-Term Lacosamide for Uncontrolled PGTC Seizures in Idiopathic Generalized Epilepsy

NCT01118962Phase 2Completed

Sponsor
UCB
Start
Aug 2010
Primary completion
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lacosamide in idiopathic generalized epilepsy (IGE), sponsored by UCB. Started Aug 2010; status: completed.

02

Drugs

lacosamide
03

Conditions

idiopathic generalized epilepsy (IGE)

Beyond the preview

Go deeper on NCT01118962.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01118962.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call